SCHEMBL18558147

SCHEMBL18558147

CCCCNC(=O)c1cccc2cn[nH]c12

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 3/20 0.59
HDAC3 O15379 2/20 0.59
TSHR P16473 1/20 0.57
HTT P42858 1/20 0.57
PLK4 O00444 1/20 0.54
CHEK1 O14757 1/20 0.54
AURKA O14965 1/20 0.54
DAPK3 O43293 1/20 0.54
MAP4K4 O95819 1/20 0.54
CSF1R P07333 1/20 0.54
RET P07949 1/20 0.54
FGFR1 P11362 1/20 0.54
PDGFRA P16234 1/20 0.54
LTK P29376 1/20 0.54
KDR P35968 1/20 0.54
MAP2K2 P36507 1/20 0.54
FLT3 P36888 1/20 0.54
CSNK1A1 P48729 1/20 0.54
PRKX P51817 1/20 0.54
CDK5 Q00535 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18397650 0.80 PLK4 (0.55) HDAC1HDAC3PLK4CHEK1AURKA
SCHEMBL24433138 0.79 PLK4 (0.64) HDAC1HDAC3TSHRPLK4CHEK1
SCHEMBL10244809 0.78 HDAC1 (0.67) HDAC1HDAC3TSHRHTTHPGD
SCHEMBL22470277 0.78 HDAC1 (0.56) HDAC1HDAC3PLK4CHEK1AURKA
SCHEMBL15786485 0.75 PLK4 (0.59) HDAC1HDAC3TSHRPLK4CHEK1
SCHEMBL29768842 0.75 PLK4 (0.59) HDAC1HDAC3TSHRPLK4CHEK1
SCHEMBL1937915 0.75 HDAC3 (1.00) HDAC1HDAC3
SCHEMBL19210845 0.75 TSHR (1.00) TSHRHTTHPGDL3MBTL1SMN1; SMN2
SCHEMBL24992498 0.75 PLK4 (0.62) HDAC1HDAC3TSHRPLK4CHEK1
SCHEMBL1093718 0.75 TSHR (0.73) HDAC1HDAC3TSHRHTTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2928473-B1 REGIOSELECTIVE N-2 ARYLATION OF INDAZOLES MERCK SHARP & DOHME (US) 2017-06-28 EP disclosed
US-20170137403-A1 REGIOSELECTIVE N-2 ARYLATION OF INDAZOLES MERCK SHARP & DOHME CORP. (US) 2017-05-18 US disclosed
US-9580407-B2 Regioselective N-2 arylation of indazoles MERCK SHARP & DOHME CORP. (US) 2017-02-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170137403-A1 REGIOSELECTIVE N-2 ARYLATION OF INDAZOLES PARP2, PARP1, PARP12 HDAC1 413/4885HDAC3 642/4885TSHR 3698/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.